View ValuationHydrapres 将来の成長Future 基準チェック /06現在、 Hydrapresの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Machinery 収益成長15.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 03Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026分析記事 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.分析記事 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).お知らせ • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.お知らせ • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.お知らせ • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.お知らせ • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.お知らせ • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Hydrapres は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測WSE:HPS - アナリストの将来予測と過去の財務データ ( )PLN Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/202531-5-1-1N/A6/30/202532-5-2-2N/A3/31/202533-6-3-3N/A12/31/202434-5-4-3N/A9/30/202433-6-6-6N/A6/30/202434-6-291-325N/A3/31/202435-6-3-3N/A12/31/202338-622N/A9/30/202339-612N/A6/30/202342-4287322N/A3/31/202343-200N/A12/31/202244-1-5-5N/A9/30/2022420-6-5N/A6/30/2022390-6-5N/A3/31/2022350-5-4N/A12/31/2021330-2-2N/A9/30/202132100N/A6/30/202130122N/A3/31/202127033N/A12/31/202026044N/A9/30/202029033N/A6/30/202031023N/A3/31/202036144N/A12/31/201938023N/A9/30/201938134N/A6/30/2019380N/A4N/A3/31/2019411N/A3N/A12/31/2018431N/A5N/A9/30/2018461N/A2N/A6/30/2018480N/A1N/A3/31/201849-1N/A1N/A12/31/201750-1N/A-1N/A9/30/201750-2N/A3N/A6/30/201750-1N/A2N/A3/31/2017501N/A2N/A12/31/201651-1N/A3N/A9/30/2016541N/A4N/A6/30/2016531N/A4N/A3/31/201651-1N/A3N/A12/31/2015500N/A2N/A9/30/2015440N/A2N/A6/30/2015410N/A3N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: HPSの予測収益成長が 貯蓄率 ( 5.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: HPSの収益がPolish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: HPSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: HPSの収益がPolish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: HPSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: HPSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 15:28終値2026/06/09 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hydrapres S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 03Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).
New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).
お知らせ • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
分析記事 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
お知らせ • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025
New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
分析記事 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).
お知らせ • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.
New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).
Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).
Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
お知らせ • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023
Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.
Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022
Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.
お知らせ • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021
Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.
Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.